EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pleurotus sajor-caju (Fr.) Singer β-1,3-Glucanoligosaccharide (Ps-GOS) Suppresses RANKL-Induced Osteoclast Differentiation and Function in Pre-Osteoclastic RAW 264.7 Cells by Inhibiting the RANK/NFκB/cFOS/NFATc1 Signalling Pathway

Purithat Rattajak, Aratee Aroonkesorn, Carl Smythe iD, Rapepun Wititsuwannakul, Thanawat Pitakpornpreecha iD

Molecules · 2024

DOI: 10.3390/molecules29092113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Purithat Rattajak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health and Applied Science (Biochemistry), Faculty of Science, Prince of Songkla University, Hat-Yai, Songkhla 90110, Thailand. Hauptthemen laut MEDLINE: Cell Differentiation, Oligosaccharides, Osteoclasts, Pleurotus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thailand's Education Hub for the Southern Region of ASEAN Countries, Master Labs Incorporation Co., Ltd., government budget, Scholarship Awards for Thai Ph.D. Students.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Edible grey oyster mushroom, Pleurotus sajor-caju, β (1,3), (1,6) glucan possesses a wide range of biological activities, including anti-inflammation, anti-microorganism and antioxidant. However, its biological activity is limited by low water solubility resulting from its high molecular weight. Our previous study demonstrated that enzymatic hydrolysis of grey oyster mushroom β-glucan using Hevea β-1,3-glucanase isozymes obtains a lower molecular weight and higher water solubility, Pleurotus sajor-caju glucanoligosaccharide (Ps-GOS). Additionally, Ps-GOS potentially reduces osteoporosis by enhancing osteoblast–bone formation, whereas its effect on osteoclast–bone resorption remains unknown. Therefore, our study investigated the modulatory activities and underlying mechanism of Ps-GOS on Receptor activator of nuclear factor kappa-Β ligand (RANKL) -induced osteoclastogenesis in pre-osteoclastic RAW 264.7 cells. Cell cytotoxicity of Ps-GOS on RAW 264.7 cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and its effect on osteoclast differentiation was determined by tartrate-resistant acid phosphatase (TRAP) staining. Additionally, its effect on osteoclast bone-resorptive ability was detected by pit formation assay. The osteoclastogenic-related factors were assessed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), Western blot and immunofluorescence. The results revealed that Ps-GOS was non-toxic and significantly suppressed the formation of mature osteoclast multinucleated cells and their resorption activity by reducing the number of TRAP-positive cells and pit formation areas in a dose-dependent manner. Additionally, Ps-GOS attenuated the nuclear factor kappa light chain-enhancer of activated B cells’ P65 (NFκB-P65) expression and their subsequent master osteoclast modulators, including nuclear factor of activated T cell c1 (NFATc1) and Fos proto-oncogene (cFOS) via the NF-κB pathway. Furthermore, Ps-GOS markedly inhibited RANK expression, which serves as an initial transmitter of many osteoclastogenesis-related cascades and inhibited proteolytic enzymes, including TRAP, matrix metallopeptidase 9 (MMP-9) and cathepsin K (CTK). These findings indicate that Ps-GOS could potentially be beneficial as an effective natural agent for bone metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationOligosaccharidesOsteoclastsPleurotusSignal TransductionAnimalsMicebeta-GlucansNF-kappa BNFATC Transcription FactorsOsteogenesisProto-Oncogene Proteins c-fosRANK LigandRAW 264.7 CellsReceptor Activator of Nuclear Factor-kappa B

Stichwörter der Autor:innen

Pleurotus sajor-cajuglucanoligosaccharideosteoclastogenesisosteoporosis

Substanzen

beta-GlucansNF-kappa BNFATC Transcription FactorsNfatc1 protein, mouseOligosaccharidesProto-Oncogene Proteins c-fosRANK LigandReceptor Activator of Nuclear Factor-kappa BTnfrsf11a protein, mouseTnfsf11 protein, mouse

Autor:innen und Institutionen

  • Division of Health and Applied Science (Biochemistry), Faculty of Science, Prince of Songkla University, Hat-Yai, Songkhla 90110, Thailand.
  • Center for Natural Rubber Latex Biotechnology Research and Innovation Development, Prince of Songkla University, Hat-Yai, Songkhla 90110, Thailand.
  • Department of Biomedical Science, University of Sheffield, Sheffield S10 2TN, UK.

ORCID-Profile: Carl Smythe, Thanawat Pitakpornpreecha

Förderung

  • Thailand's Education Hub for the Southern Region of ASEAN Countries
  • Master Labs Incorporation Co., Ltd.
  • government budget, Scholarship Awards for Thai Ph.D. Students
  • Graduate School, Prince of Songkla University, Songkhla, Thailand; and Innozus Co., Ltd. (Master labs incorporation Co., Ltd.), Bangkok, Thailand

Zitieren

APA

Rattajak, P., Aroonkesorn, A., Smythe, C., Wititsuwannakul, R., & Pitakpornpreecha, T. (2024). Pleurotus sajor-caju (Fr.) Singer β-1,3-Glucanoligosaccharide (Ps-GOS) Suppresses RANKL-Induced Osteoclast Differentiation and Function in Pre-Osteoclastic RAW 264.7 Cells by Inhibiting the RANK/NFκB/cFOS/NFATc1 Signalling Pathway. Molecules. https://doi.org/10.3390/molecules29092113

Vancouver

Rattajak P, Aroonkesorn A, Smythe C, Wititsuwannakul R, Pitakpornpreecha T. Pleurotus sajor-caju (Fr.) Singer β-1,3-Glucanoligosaccharide (Ps-GOS) Suppresses RANKL-Induced Osteoclast Differentiation and Function in Pre-Osteoclastic RAW 264.7 Cells by Inhibiting the RANK/NFκB/cFOS/NFATc1 Signalling Pathway. Molecules. 2024. doi:10.3390/molecules29092113

BibTeX
@article{Rattajak2024,
  author = {Rattajak, Purithat and Aroonkesorn, Aratee and Smythe, Carl and Wititsuwannakul, Rapepun and Pitakpornpreecha, Thanawat},
  title = {Pleurotus sajor-caju (Fr.) Singer β-1,3-Glucanoligosaccharide (Ps-GOS) Suppresses RANKL-Induced Osteoclast Differentiation and Function in Pre-Osteoclastic RAW 264.7 Cells by Inhibiting the RANK/NFκB/cFOS/NFATc1 Signalling Pathway},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29092113}
}
Kostenlos starten →